Clinical Science Liaison US
Pentixapharm AG
Summary
As our Clinical Science Liaison for the East Coast, you will be the scientific partner of our investigator sites and a visible scientific voice for Pentixapharm. You will make sure investigators and site staff understand our trials, help sites solve problems quickly, and support leadership in explaining our science and clinical progress to external stakeholders, including investors.
Job description
Job Overview
As our Clinical Science Liaison for the East Coast, you will be the scientific partner of our investigator sites and a visible scientific voice for Pentixapharm. You will make sure investigators and site staff understand our trials, help sites solve problems quickly, and support leadership in explaining our science and clinical progress to external stakeholders, including investors.
Your Tasks
- Serve as the primary scientific contact for investigators and site staff: answer protocol questions, provide study training, and ensure scientific alignment across sites
- Support site initiation, activation and ongoing study conduct, working closely with Clinical Operations
- Proactively follow up with sites, identify obstacles early (enrollment, documentation, data quality) and help resolve them
- Support sites with trial documentation and protocol-related issues in line with GCP
- Identify and evaluate potential new investigator sites and support feasibility assessments
- Build relationships with clinical experts and key opinion leaders on the East Coast
- Present scientific and clinical progress clearly to leadership and investors, together with the executive team
- Provide scientific intelligence on clinical trends, investigator feedback and emerging opportunities
- Represent Pentixapharm at key scientific congresses
- Support regulatory interactions with the FDA and at clinical trial site level
Experience & Skills
- Advanced degree (MS/PhD) in life sciences, or NP/RN/PharmD with substantial clinical trial experience
- Substantial experience in a CSL, MSL, clinical scientist, CRA or other field-based clinical role, ideally in oncology
- Solid understanding of clinical trial operations, GCP and ICH guidelines, including trial documentation
- Strong scientific communicator who can explain complex science clearly to investigators, site staff and non-scientific audiences such as investors
- Proactive, confident and persistent when working with sites, while staying professional and collaborative
- Experience in radiopharmaceuticals, nuclear medicine or PET is a plus
- Willingness to travel approximately 50-60% to investigator sites and conferences
Requirements
- Advanced degree (MS/PhD) in life sciences, or NP/RN/PharmD with substantial clinical trial experience
- Substantial experience in a CSL, MSL, clinical scientist, CRA or other field-based clinical role, ideally in oncology
- Solid understanding of clinical trial operations, GCP and ICH guidelines, including trial documentation
- Strong scientific communicator who can explain complex science clearly to investigators, site staff and non-scientific audiences such as investors
- Proactive, confident and persistent when working with sites, while staying professional and collaborative
- Experience in radiopharmaceuticals, nuclear medicine or PET is a plus
- Willingness to travel approximately 50-60% to investigator sites and conferences
Benefits
- Flexible Hours
- Hybrid Work
- High Responsibility
- Direct Access to Leadership
Company overview
Pentixapharm AG (Pentixapharm Holding AG) is a clinical-stage biopharmaceutical company based in Würzburg, Germany, founded in 2019. The company specializes in the research, development, and commercialization of radiopharmaceuticals, with a core focus on CXCR4 ligand-based compounds for diagnostic and therapeutic applications. Its lead platform leverages the CXCR4 chemokine receptor, which is overexpressed in various hematologic and solid tumors, enabling both imaging (diagnostics) and targeted radioligand therapy in a theranostic approach. Pentixapharm's pipeline addresses indications including blood cancers, adrenal and renal tumors, and other CXCR4-related conditions. The company has administered its investigational compounds to over 2,000 patients and is publicly listed on the Frankfurt Stock Exchange. As a specialized radiopharmaceutical innovator, Pentixapharm combines nuclear medicine expertise with drug development to advance precision oncology and theranostic solutions for unmet clinical needs.